BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 19214609)

  • 1. Dendritic-cell- and peptide-based vaccination strategies for glioma.
    Yamanaka R
    Neurosurg Rev; 2009 Jul; 32(3):265-73; discussion 273. PubMed ID: 19214609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peptide vaccination therapy for malignant glioma].
    Yamanaka R; Itoh K
    Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-based immunotherapeutic approaches to glioma: a review.
    Yamanaka R; Itoh K
    Expert Opin Biol Ther; 2007 May; 7(5):645-9. PubMed ID: 17477802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel immunotherapeutic approaches to glioma.
    Yamanaka R
    Curr Opin Mol Ther; 2006 Feb; 8(1):46-51. PubMed ID: 16506525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell- and peptide-based immunotherapeutic approaches for glioma.
    Yamanaka R
    Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell vaccines.
    Yamanaka R; Kajiwara K
    Adv Exp Med Biol; 2012; 746():187-200. PubMed ID: 22639169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dendritic cell therapy for malignant glioma].
    Yamanaka R; Homma J; Yajima N; Tsuchiya N; Tanaka R
    No To Shinkei; 2003 Sep; 55(9):771-80. PubMed ID: 14571839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell-based glioma immunotherapy (review).
    Yamanaka R; Yajima N; Abe T; Tsuchiya N; Homma J; Narita M; Takahashi M; Tanaka R
    Int J Oncol; 2003 Jul; 23(1):5-15. PubMed ID: 12792771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell immunotherapy for malignant gliomas.
    Luptrawan A; Liu G; Yu JS
    Rev Recent Clin Trials; 2008 Jan; 3(1):10-21. PubMed ID: 18474011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.
    Everson RG; Graner MW; Gromeier M; Vredenburgh JJ; Desjardins A; Reardon DA; Friedman HS; Friedman AH; Bigner DD; Sampson JH
    Expert Rev Anticancer Ther; 2008 May; 8(5):717-32. PubMed ID: 18471045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review.
    Wang X; Zhao HY; Zhang FC; Sun Y; Xiong ZY; Jiang XB
    Cancer Invest; 2014 Nov; 32(9):451-7. PubMed ID: 25259676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide vaccine.
    Izumoto S
    Adv Exp Med Biol; 2012; 746():166-77. PubMed ID: 22639167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of diffuse gliomas: biological background, current status and future developments.
    Grauer OM; Wesseling P; Adema GJ
    Brain Pathol; 2009 Oct; 19(4):674-93. PubMed ID: 19744040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell-based immunotherapy of malignant gliomas.
    Parajuli P; Sloan AE
    Cancer Invest; 2004; 22(3):405-16. PubMed ID: 15493362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell vaccines and immunity in glioma patients.
    Wheeler CJ; Black KL
    Front Biosci; 2005 Sep; 10():2861-81. PubMed ID: 15970541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-1 and immunotherapy for brain cancer.
    Verschuere T; De Vleeschouwer S; Lefranc F; Kiss R; Van Gool SW
    Expert Rev Neurother; 2011 Apr; 11(4):533-43. PubMed ID: 21469926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.
    Maxwell R; Luksik AS; Garzon-Muvdi T; Lim M
    Curr Neurol Neurosci Rep; 2017 Jun; 17(6):50. PubMed ID: 28488122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell immunity in patients with malignant glioma: recent progress in dendritic cell-based immunotherapeutic approaches.
    Akasaki Y; Black KL; Yu JS
    Front Biosci; 2005 Sep; 10():2908-21. PubMed ID: 15970545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell therapy of high-grade gliomas.
    Van Gool S; Maes W; Ardon H; Verschuere T; Van Cauter S; De Vleeschouwer S
    Brain Pathol; 2009 Oct; 19(4):694-712. PubMed ID: 19744041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ dendritic cell vaccination for the treatment of glioma and literature review.
    Li M; Han S; Shi X
    Tumour Biol; 2016 Feb; 37(2):1797-801. PubMed ID: 26318301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.